 |
|
|
| |
Characteristics of HCV-Infected Patients With Cirrhosis Requiring Ribavirin Dose Reduction During Treatment With Direct-Acting Antivirals
|
| |
| |
Reported by Jules Levin
AASLD 2014 Nov 7-11 Boston
Ira M Jacobson1, Xavier Forns2, Stefan Zeuzem3, Christophe Hézode4, Mitchell L Shiff man5, Stanislas Pol6, Marina Berenguer7, Michael W Fried8, Kosh Agarwal9, Kris V Kowdley10, Sandra Lovell11, Manal Abunimeh11, Roger Trinh11, Barbara McGovern11, Antonio Craxi12, Fred Poordad13
1Weill Cornell Medical College, New York, New York, United States; 2Liver Unit, Hospital Clinic, IDIBAPS, CIBERehd, Barcelona, Spain; 3JW Goethe University, Frankfurt, Germany; 4Mondor Hospital, Creteil, France; 5Liver Institute of Virginia, Bon Secours Health System, Newport News, Virginia, United States;
6Groupe Hospitalier Cochin-Saint Vincent De Paul, Paris, France; 7Hospital Universitario La Fe, Valencia, Spain; 8University of North Carolina, Chapel Hill, North Carolina, United States; 9Insti tute of Liver Studies, Kings College Hospital, London, United Kingdom; 10Digesti ve Disease Institute, Virginia Mason
Medical Center, Seatt le, Washington, United States; 11AbbVie Inc., North Chicago, Illinois, United States; 12AOU Policlinico "P Giaccone" Dip. Di Gastroenterologia ed Epatologia DBMIS, Palermo, Italy; 13The Texas Liver Institute-University of Texas Health Science Center, San Antonio, Texas, United States
|
| |
|
|
|
|
|
